HUP0303241A2 - Pirazolil-pirimidin-származékok, előállításuk, alkalmazásuk és az előállításukhoz használt köztitermékek - Google Patents

Pirazolil-pirimidin-származékok, előállításuk, alkalmazásuk és az előállításukhoz használt köztitermékek

Info

Publication number
HUP0303241A2
HUP0303241A2 HU0303241A HUP0303241A HUP0303241A2 HU P0303241 A2 HUP0303241 A2 HU P0303241A2 HU 0303241 A HU0303241 A HU 0303241A HU P0303241 A HUP0303241 A HU P0303241A HU P0303241 A2 HUP0303241 A2 HU P0303241A2
Authority
HU
Hungary
Prior art keywords
group
alkyl
general formula
chlorine
fluorine
Prior art date
Application number
HU0303241A
Other languages
English (en)
Hungarian (hu)
Inventor
Bernd Alig
Thomas Bretschneider
Christoph Erdelen
Mazen Es-Sayed
Rüdiger Fischer
Peter Lösel
Udo Reckmann
Original Assignee
Bayer Cropscience Ag
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed by Bayer Cropscience Ag filed Critical Bayer Cropscience Ag
Publication of HUP0303241A2 publication Critical patent/HUP0303241A2/hu

Links

Classifications

    • C—CHEMISTRY; METALLURGY
    • C07—ORGANIC CHEMISTRY
    • C07D—HETEROCYCLIC COMPOUNDS
    • C07D401/00—Heterocyclic compounds containing two or more hetero rings, having nitrogen atoms as the only ring hetero atoms, at least one ring being a six-membered ring with only one nitrogen atom
    • C07D401/02—Heterocyclic compounds containing two or more hetero rings, having nitrogen atoms as the only ring hetero atoms, at least one ring being a six-membered ring with only one nitrogen atom containing two hetero rings
    • C07D401/04—Heterocyclic compounds containing two or more hetero rings, having nitrogen atoms as the only ring hetero atoms, at least one ring being a six-membered ring with only one nitrogen atom containing two hetero rings directly linked by a ring-member-to-ring-member bond
    • C—CHEMISTRY; METALLURGY
    • C07—ORGANIC CHEMISTRY
    • C07D—HETEROCYCLIC COMPOUNDS
    • C07D239/00—Heterocyclic compounds containing 1,3-diazine or hydrogenated 1,3-diazine rings
    • C07D239/02—Heterocyclic compounds containing 1,3-diazine or hydrogenated 1,3-diazine rings not condensed with other rings
    • C07D239/24—Heterocyclic compounds containing 1,3-diazine or hydrogenated 1,3-diazine rings not condensed with other rings having three or more double bonds between ring members or between ring members and non-ring members
    • C07D239/28—Heterocyclic compounds containing 1,3-diazine or hydrogenated 1,3-diazine rings not condensed with other rings having three or more double bonds between ring members or between ring members and non-ring members with hetero atoms or with carbon atoms having three bonds to hetero atoms with at the most one bond to halogen, directly attached to ring carbon atoms
    • C07D239/32—One oxygen, sulfur or nitrogen atom
    • C07D239/34—One oxygen atom
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P33/00—Antiparasitic agents
    • A61P33/14—Ectoparasiticides, e.g. scabicides
    • C—CHEMISTRY; METALLURGY
    • C07—ORGANIC CHEMISTRY
    • C07D—HETEROCYCLIC COMPOUNDS
    • C07D239/00—Heterocyclic compounds containing 1,3-diazine or hydrogenated 1,3-diazine rings
    • C07D239/02—Heterocyclic compounds containing 1,3-diazine or hydrogenated 1,3-diazine rings not condensed with other rings
    • C07D239/24—Heterocyclic compounds containing 1,3-diazine or hydrogenated 1,3-diazine rings not condensed with other rings having three or more double bonds between ring members or between ring members and non-ring members
    • C07D239/28—Heterocyclic compounds containing 1,3-diazine or hydrogenated 1,3-diazine rings not condensed with other rings having three or more double bonds between ring members or between ring members and non-ring members with hetero atoms or with carbon atoms having three bonds to hetero atoms with at the most one bond to halogen, directly attached to ring carbon atoms
    • C07D239/32—One oxygen, sulfur or nitrogen atom
    • C07D239/42—One nitrogen atom
    • C—CHEMISTRY; METALLURGY
    • C07—ORGANIC CHEMISTRY
    • C07D—HETEROCYCLIC COMPOUNDS
    • C07D403/00—Heterocyclic compounds containing two or more hetero rings, having nitrogen atoms as the only ring hetero atoms, not provided for by group C07D401/00
    • C07D403/02—Heterocyclic compounds containing two or more hetero rings, having nitrogen atoms as the only ring hetero atoms, not provided for by group C07D401/00 containing two hetero rings
    • C07D403/04—Heterocyclic compounds containing two or more hetero rings, having nitrogen atoms as the only ring hetero atoms, not provided for by group C07D401/00 containing two hetero rings directly linked by a ring-member-to-ring-member bond
    • C—CHEMISTRY; METALLURGY
    • C07—ORGANIC CHEMISTRY
    • C07D—HETEROCYCLIC COMPOUNDS
    • C07D403/00—Heterocyclic compounds containing two or more hetero rings, having nitrogen atoms as the only ring hetero atoms, not provided for by group C07D401/00
    • C07D403/14—Heterocyclic compounds containing two or more hetero rings, having nitrogen atoms as the only ring hetero atoms, not provided for by group C07D401/00 containing three or more hetero rings

Landscapes

  • Organic Chemistry (AREA)
  • Chemical & Material Sciences (AREA)
  • Health & Medical Sciences (AREA)
  • Veterinary Medicine (AREA)
  • Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
  • Animal Behavior & Ethology (AREA)
  • General Chemical & Material Sciences (AREA)
  • Medicinal Chemistry (AREA)
  • Tropical Medicine & Parasitology (AREA)
  • Pharmacology & Pharmacy (AREA)
  • Life Sciences & Earth Sciences (AREA)
  • Chemical Kinetics & Catalysis (AREA)
  • General Health & Medical Sciences (AREA)
  • Public Health (AREA)
  • Plural Heterocyclic Compounds (AREA)
  • Pharmaceuticals Containing Other Organic And Inorganic Compounds (AREA)
  • Agricultural Chemicals And Associated Chemicals (AREA)
  • Low-Molecular Organic Synthesis Reactions Using Catalysts (AREA)
HU0303241A 2001-02-22 2002-02-11 Pirazolil-pirimidin-származékok, előállításuk, alkalmazásuk és az előállításukhoz használt köztitermékek HUP0303241A2 (hu)

Applications Claiming Priority (2)

Application Number Priority Date Filing Date Title
DE10108480A DE10108480A1 (de) 2001-02-22 2001-02-22 Pyrazolylpyrimidine
PCT/EP2002/001400 WO2002068413A1 (de) 2001-02-22 2002-02-11 Pyrazolylpyrimidine

Publications (1)

Publication Number Publication Date
HUP0303241A2 true HUP0303241A2 (hu) 2004-01-28

Family

ID=7675081

Family Applications (1)

Application Number Title Priority Date Filing Date
HU0303241A HUP0303241A2 (hu) 2001-02-22 2002-02-11 Pirazolil-pirimidin-származékok, előállításuk, alkalmazásuk és az előállításukhoz használt köztitermékek

Country Status (13)

Country Link
US (1) US7087616B2 (enExample)
EP (1) EP1363905A1 (enExample)
JP (1) JP2004524315A (enExample)
KR (1) KR100854583B1 (enExample)
CN (1) CN1301992C (enExample)
BR (1) BR0207509A (enExample)
DE (1) DE10108480A1 (enExample)
HU (1) HUP0303241A2 (enExample)
IL (1) IL157298A0 (enExample)
MX (1) MXPA03007433A (enExample)
TW (1) TWI236475B (enExample)
WO (1) WO2002068413A1 (enExample)
ZA (1) ZA200306468B (enExample)

Families Citing this family (24)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
TWI372050B (en) * 2003-07-03 2012-09-11 Astex Therapeutics Ltd (morpholin-4-ylmethyl-1h-benzimidazol-2-yl)-1h-pyrazoles
MX2007008008A (es) 2004-12-30 2007-11-12 Astex Therapeutics Ltd Compuestos de pirazol que modulan la actividad de las cinasas cdk, gsk y aurora.
DE102005058418A1 (de) * 2005-12-07 2007-06-21 Bayer Cropscience Gmbh Verfahren zur Herstellung von Haloalkyl(thio)vinimidiniumsalzen und 4-(Haloalkyl(thio))-pyrazolen und deren Umsetzung zu Pflanzenschutzmitteln
JP5474354B2 (ja) * 2005-12-30 2014-04-16 アステックス、セラピューティックス、リミテッド 医薬化合物
US8435970B2 (en) * 2006-06-29 2013-05-07 Astex Therapeutics Limited Pharmaceutical combinations of 1-cyclopropyl-3-[3-(5-morpholin-4-ylmethyl-1H-benzoimidazol-2-yl)-1H-pyrazol-4-yl]-urea
JP2009542608A (ja) * 2006-06-29 2009-12-03 アステックス・セラピューティクス・リミテッド 医薬組合せ剤
DE102007003036A1 (de) * 2006-12-20 2008-06-26 Bayer Cropscience Ag Pyrimidinylpyrazole
DE102007044032A1 (de) 2007-09-14 2009-03-19 Bayer Healthcare Ag Substituierte heterocyclische Verbindungen und ihre Verwendung
DE102007048447A1 (de) 2007-10-10 2009-04-16 Bayer Healthcare Ag Substituierte Dihydropyrazolthione und ihre Verwendung
EP2135865A1 (de) * 2008-06-17 2009-12-23 Bayer CropScience AG Substituierte 1-(Diazinyl) pyrazol-4-yl-essigsäuren, Verfahren zu deren Herstellung und deren Verwendung als Herbizide und Pflanzenwachstumsregulatoren
US20110190365A1 (en) * 2008-08-14 2011-08-04 Bayer Crop Science Ag Insecticidal 4-phenyl-1H-pyrazoles
DE112010001898T5 (de) * 2009-04-27 2012-08-02 Dow Agrosciences Llc Insektizide Pyridinverbindungen
CN102573478B (zh) * 2009-10-12 2015-12-16 拜尔农作物科学股份公司 作为杀虫剂的1-(吡啶-3-基)-吡唑和1-(嘧啶-5-基)-吡唑
AR078947A1 (es) 2009-11-11 2011-12-14 Bayer Cropscience Ag Compuestos de diazinil-pirazolilo y procesos de preparacion de los mismos
JP2012116796A (ja) * 2010-12-01 2012-06-21 Sumitomo Chemical Co Ltd ヘテロ芳香環化合物およびその有害生物防除用途
CN104302640A (zh) 2012-03-16 2015-01-21 埃克希金医药品有限公司 3,5-二氨基吡唑激酶抑制剂
NZ631142A (en) 2013-09-18 2016-03-31 Axikin Pharmaceuticals Inc Pharmaceutically acceptable salts of 3,5-diaminopyrazole kinase inhibitors
MY195016A (en) 2014-08-04 2023-01-03 Nuevolution As Optionally Fused Heterocyclyl-Substituted Derivatives of Pyrimidine Useful for The Treatment of Inflammatory, Metabolic, Oncologic and Autoimmune Diseases
WO2016057931A1 (en) 2014-10-10 2016-04-14 The Research Foundation For The State University Of New York Trifluoromethoxylation of arenes via intramolecular trifluoromethoxy group migration
MY191736A (en) 2014-12-23 2022-07-13 Axikin Pharmaceuticals Inc 3,5-diaminopyrazole kinase inhibitors
AU2020405446A1 (en) 2019-12-20 2022-05-26 Nuevolution A/S Compounds active towards nuclear receptors
BR112022012205A2 (pt) 2019-12-20 2022-09-13 Nuevolution As Compostos ativos para receptores nucleares
JP7713954B2 (ja) 2020-03-31 2025-07-28 ヌエヴォリューション・アクティーゼルスカブ 核内受容体に対して活性な化合物
CA3174252A1 (en) 2020-03-31 2021-10-07 Nuevolution A/S Compounds active towards nuclear receptors

Family Cites Families (5)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
US3910910A (en) * 1972-03-31 1975-10-07 American Home Prod (2-Pyrimidinylthio) alkanoic acids, esters, amides and hydrazides
US4663327A (en) * 1984-05-23 1987-05-05 Bayer Aktiengesellschaft 1-heteroaryl-4-aryl-pyrazolin-5-ones
EP0702670A1 (de) 1993-06-07 1996-03-27 Bayer Ag Iodpropargylcarbamate und ihre verwendung als biozide im pflanzen- und materialschutz
CN1153779A (zh) * 1995-09-28 1997-07-09 山道士有限公司 2-(4-吡唑基氧基-嘧啶-5-基)乙酸衍生物
AU5412998A (en) * 1996-12-16 1998-07-15 Sumitomo Chemical Company, Limited Pyrazoline compounds and use as plant disease control agent

Also Published As

Publication number Publication date
IL157298A0 (en) 2004-02-19
KR100854583B1 (ko) 2008-08-27
JP2004524315A (ja) 2004-08-12
US7087616B2 (en) 2006-08-08
MXPA03007433A (es) 2003-11-18
CN1492864A (zh) 2004-04-28
EP1363905A1 (de) 2003-11-26
DE10108480A1 (de) 2002-09-05
ZA200306468B (en) 2005-02-04
US20040102465A1 (en) 2004-05-27
CN1301992C (zh) 2007-02-28
TWI236475B (en) 2005-07-21
KR20030075188A (ko) 2003-09-22
WO2002068413A1 (de) 2002-09-06
BR0207509A (pt) 2004-03-09

Similar Documents

Publication Publication Date Title
NO20051411L (no) Pyrazolderivater, medisinske sammensetninger inneholdende slike, medisinsk bruk derav samt intermediater til fremstilling derav
NL300877I2 (nl) obeticholzuur
MY136959A (en) Quinoline intermediates of receptor tyrosine kinase inhibitors and the synthesis thereof
TW200635585A (en) Monocyclic substituted methanones
TW200732329A (en) Aryl-isoxazolo-4-yl-oxadiazole derivatives
NO20023823D0 (no) Fremgangsmåte for tilvirkning og bruk av pyrrolopyrimidinon- derivater
HUP0300920A1 (hu) Szubsztituált benzidszármazékok és gyógyszerként történő felhasználásuk
SE0200411D0 (sv) Novel use
BR0208805A (pt) Uso de um derivado de pirazolina
MX2009012380A (es) Compuestos de heteroarilamida pirimidona.
ATE396182T1 (de) Hemmstoffe des ep4-rezeptors
KR101514593B1 (ko) 5-(메틸-1h-이미다졸-1-일)-3-(트리플루오로메틸)-벤젠아민의 합성 방법
EA200971063A1 (ru) Ариламидпиримидоновые соединения
HUP0001957A2 (hu) Gombaellenes hatású, piridingyűrűben karbonsavszármazékokkal helyettesített 2-(metoxi-imino)-2-(piridinil-oxi-metil)-fenil-acetamid-származékok, intermedierjeik, előállításuk és alkalmazásuk
DE60327922D1 (de) Harnstoff-linker verbindungen und ihre verwendung als ppar regulatoren
ATE482933T1 (de) Sulfopyrrolderivate
HUP0003942A2 (hu) Helyettesített 3,3-diamino-2-propén-nitrilek, előállításuk és alkalmazásuk
DK1694641T3 (da) Prostaglandinsyntese
HUP9801056A2 (hu) Apolipoprotein-B szintézist gátló triazolonszármazékok, eljárás előállításukra, alkalmazásuk és az ezeket tartalmazó gyógyszerkészítmények
NO20062936L (no) Fremgangsmate for fremstilling av N-alkyl-2(hydroksy-4-benzoyl)-3-benzofuraner og dets mellomprodukter derav
TW200619201A (en) Process for the preparation of pyrazoles
DK1347960T3 (da) Fremgangsmåde til fremstilling af (+/-) trans-4-p-fluorphenyl-3-hydromethyl-1-methylpiperidin
DE602005008099D1 (de) Pyrrolopyridin-2-karbonsäureamid-derivat zur verwendung als inhibitor gegen glykogenphosphorylase
UA98834C2 (ru) 19-НОР-СТЕРОИДНЫЕ ПРОИЗВОДНЫЕ С 15α,16α-МЕТИЛЕНОВОЙ ГРУППОЙ И НАСЫЩЕННЫМ 17,17-СПИРОЛАКТОНОВЫМ КОЛЬЦОМ, ИХ ПРИМЕНЕНИЕ И ЛЕКАРСТВЕННОЕ СРЕДСТВО, КОТОРОЕ СОДЕРЖИТ ЭТИ ПРОИЗВОДНЫЕ
TR200003877T2 (tr) İnsan CD23 üretiminin ve TNF salınmasının ihhibitörleri olan hiydroxamic acid türevleri